Benzinga's M&A Chatter for Tuesday July 5, 2016

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday July 5, 2016: Medivation in Talks With Sanofi Following Sweetened Offer The Rumor:
Shares of Medivation MDVN spiked higher Tuesday, following a report from Reuters that it was in talks with Sanofi SNY over a sweetened offer. Meidvation later confirmed it had received and rejected an offer of $58.00 per share in cash from Sanfoi, plus a CVR for Talazoparib sales, worth up to $3.00 per share. Medivation said it had entered into confidentiality agreements with a number of parties that have expressed interest in exploring a potential transaction. Medivation closed at $61.76 on Tuesday and traded as high as $62.90 after-hours. KKR to Acquire Epicor The Deal:
KKR & Co. KKR has agreed to Epicor Software Corp. from Apax Partners. Terms were not disclosed, but Bloomberg reported that the purchase price was $3.3 billion. KKR closed Tuesday at $12.06, down $0.28. VWR Acquires BioScience Products The Deal:
VWR VWR announced Tuesday, that it has acquired PAW BioScience Products, Inc. PAW is a manufacturer and distributor of sanitary fluid handling products used in the biotechnology, biopharmaceutical and diagnostic industries. Financial details of the deal are confidential. VWR closed at $28.56 on Tuesday, down 1.92%.